Biopharmaceutical Analysis

Articles

Bionique Testing Laboratories has been acquired by Asahi Kasei Medical and will join the company’s biosafety testing services unit.

Asahi Kasei Medical Acquires Bionique

Hari Narayanan, PhD, is product marketing manager at Thermo Fisher Scientific.

Fully automated enzyme analysis can ease a persistent bottleneck in biocatalyst development for bio/pharmaceutical applications.

Advancing Enzyme Analysis

The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.

Roche Expands PCR-Test Portfolio with Completion of Purchase Agreement of TIB Molbiol

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Timing is everything, and it might be ideal for acceleration of real-time monitoring solutions. 

Process Analytical Technologies for Manufacturing Cell and Gene Therapies

Defining expectations, such as GMPs, is paramount for sourcing the right biopharmaceutical raw materials.

Ensuring Quality When Sourcing Biopharmaceutical Raw Materials 

Feliza Mirasol is the science editor for 

Confounding signals pose challenges to analytical methods necessary for managing residual impurity removal in biotherapeutic manufacturing.

Managing Residual Impurities in Complex Biotherapeutics

Glycosylation monitoring has been heavily dependent on manual processes, but the automation of sample preparation streamlines the overall workflow.

Streamlining Glycosylation Monitoring through Automation

Chris Spivey is the editorial director of 

Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.

Advances in Molecule Characterization and Biomanufacturing for Emerging Therapies: Part 2

Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.

Advances in Molecule Characterization and Biomanufacturing for Emerging Therapies: Part 1 

Gentronix has expanded it lab facilities and increased capacity for genetic, ocular, and skin toxicology testing.

Analytical Methods